Trials / Completed
CompletedNCT00367562
Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
Phase IV Open Label Uncontrolled Trial of the Dual Blockade of the Renin Angiotensin System With Enalapril Plus Valsartan Combined With Oral Methylprednisolone for the Treatment of Proteinuria in IGA Nephropathy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Hospital Britanico · Academic / Other
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
TO ASSESS THE EFFICACY OF THE RENIN ANGIOTENSIN SYSTEM PLUS STEROIDS TO DECREASE THE AMOUNT OF PROTEINURIA IN IGA NEPHROPATHY
Detailed description
Patients whose proteinuria was \> 0.5 g/day were to receive enalapril plus valsartan coupled with oral 0.5 g/day of methylprednisone for 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ENALAPRIL VALSARTAN METHYLPREDNISONE |
Timeline
- Start date
- 1996-01-01
- Completion
- 2005-12-01
- First posted
- 2006-08-23
- Last updated
- 2006-11-01
Locations
1 site across 1 country: Argentina
Source: ClinicalTrials.gov record NCT00367562. Inclusion in this directory is not an endorsement.